RUO supplier
Official terms and intended-use policy reviewed
Deep research review
Peptide Partners, which its terms identify as operated by Pirsek Technologies LLC, publishes extensive multi-laboratory certification tables. The underlying manufacturing partners are represented by codes rather than legal names. Reddit discussion is mixed, promotional, and low confidence and should not affect analytical scoring.
What this review did not check: Public analytical records and community anecdotes must remain separate.
Active storefront observed
The official storefront and public certification tables were accessible on the review date.
Current legal standing of the disclosed operator was not independently confirmed.
Findings
Disclosed Operator
The terms identify Peptide Partners as operated by Pirsek Technologies LLC and select Wyoming law.
Limit: Current Wyoming registry standing was not independently confirmed in this review.
Unsupported Marketing Claim
The home page calls the company the number one rated peptide vendor in overall quality.
Limit: No independent rating methodology supporting the claim was identified.
Manufacturer Identity Gap
The certification table uses manufacturer codes such as WF03 and VI32 rather than naming the underlying producers.
Limit: The codes do not establish manufacturer identity, custody, or legal standing.
Public Catalog
The public catalog includes individual compounds, blends, and multiple size variants.
Limit: Catalog contents and inventory can change.
Public Multi Lab Tables
Public tables expose peptide, batch ID, manufacturer code, date, reported purity, laboratory, report link, and a double-validated state, with separate endotoxin and sterility tables.
Limit: The meaning of double validated and the relationship between displayed lots and current inventory require clarification.
Public sample report
An AOD-9604 report for batch AO202605 and manufacturer code WF03 reports 99.935% purity, 9.68 mg net content, AOD-9604 identity, an endotoxin pass, and a no-growth sterility result.
Limit: The result applies only to the submitted sample. The coded manufacturer is not publicly identified.
Public sample report
An Epithalon report for batch ET202604 and manufacturer code WF03 reports 99.863% purity, 42.15 mg net content, an endotoxin pass, and a no-growth sterility result.
Limit: The result applies only to the submitted sample. The coded manufacturer is not publicly identified.
Named relationships
named-in-public-certification-table
Limit: Coverage varies by compound and lot.
named-in-public-certification-table
Limit: Coverage varies by compound and lot.
named-in-public-certification-table
Limit: Coverage varies by compound and lot.
named-in-public-certification-table
Limit: Coverage varies by compound and lot.
Search limits
Limited regulatory search
No exact-name FDA warning letter, recall, or enforcement page surfaced in the limited FDA-site search.
Limit: Search absence is not regulatory clearance.
Mixed discussion excluded from scoring
Mixed, commercially influenced Reddit discussion was observed and excluded from analytical scoring.
Limit: One large thread was removed and the remaining discussion contains extensive source-solicitation behavior. This signal does not verify product identity, quality, or health outcomes.
Open company questions
Observable documentation fields
This measures fields in normalized public records. It does not score product quality, sterility, legal compliance, or suitability.
Normalized batch records
Each row becomes a stacked record on smaller screens. Coverage means the field appears in the source record. It is not a Peptide Report pass or independent reproduction.
| Product | Batch | Laboratory | Date | Methods | Fields present | Record |
|---|---|---|---|---|---|---|
| AOD-9604 10 mg research material | AO202605 | Kovera Labs | Apr 20, 2026 | RP-HPLC, LC-MS, LAL, Microbial screen, Heavy metals | identity, purity, net Content, endotoxin, sterility, heavy Metals | Source report |
| Glow research blend | GW202603 | Kovera Labs | Mar 1, 2026 | HPLC, LC-MS | identity, purity, net Content | Source report |
Observed catalog records
The reviewed official terms establish RUO restrictions. Product-level analytical coverage still needs systematic review.
Profile ownership: unclaimed. Company representatives will be able to propose identity and catalog updates without changing editorial or regulatory records.
These secondary directories helped identify the company. Their rankings and verification labels are not adopted by Peptide Report.